Summary

The global EPA & DHA (Omega 3) Ingredients market size is predicted to grow from US$ 2357 million in 2025 to US$ 3432 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
In 2025, global EPA & DHA (Omega 3) Ingredients production reached approximately 135,318 tons, with a average price of 17.8 USD/kg.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two long-chain Omega-3 polyunsaturated fatty acids that are vital for human health. They are primarily found in deep-sea cold-water fish, shellfish, and microalgae. Since the human body converts plant-derived fatty acids (ALA) into EPA and DHA with extremely low efficiency, obtaining them directly through diet or nutritional supplements remains the only practical means of maintaining adequate levels within the body.
EPA & DHA (Omega 3) Ingredients are long-chain omega-3 polyunsaturated fatty acids. EPA refers to eicosapentaenoic acid, while DHA refers to docosahexaenoic acid. They are key functional lipids associated with cardiovascular health, neurodevelopment, retinal function, inflammatory modulation, and lipid metabolism. In industrial terms, EPA & DHA (Omega 3) Ingredients are not simply equivalent to generic fish oil; they refer to nutritional ingredients, food additives, pharmaceutical raw materials, and functional health products produced from fish oil, algal oil, krill oil, and certain marine by-product oils through refining, concentration, purification, esterification, re-esterification, microencapsulation, or dosage-form processing. Commercial forms include refined oils, concentrated oils, ethyl ester oils, triglyceride oils, powders, emulsions, softgels, liquid formulations, and pharmaceutical-grade high-purity EPA/DHA ingredients. Major applications include dietary supplements, infant formula, functional food and beverages, clinical nutrition, prescription omega-3 products, and pet nutrition.
The EPA & DHA (Omega 3) Ingredients industry is mainly built around two production models: marine oil extraction and concentration, and microalgae fermentation followed by oil extraction and refining. The marine route uses sources such as Peruvian anchovy, sardine, tuna by-products, mackerel, and cod liver oil, followed by crude oil sourcing, degumming, deacidification, bleaching, deodorization, molecular distillation, esterification/re-esterification, concentration, and antioxidant stabilization to produce refined fish oil, medium-to-high concentration EPA/DHA oils, and premium rTG products. The algal route is built on microalgae strains, fermentation tanks, culture media, extraction, and refining, making it suitable for vegan, sustainable, infant nutrition, and premium supplement applications. Industry gross margins vary significantly: low-concentration refined fish oils and commodity-grade materials are typically around 12%–25%; medium-to-high concentration oils, powders, and customized formulations are around 25%–45%; pharmaceutical-grade high-purity EPA, proprietary algal oils, and high-concentration rTG products can reach around 40%–65%. Actual profitability is influenced by fish oil raw material prices, Peruvian anchovy seasons, oxidative stability, certification systems, regulatory registrations, and long-term customer contracts. The upstream chain focuses on marine resources, algal strains, and fermentation inputs; midstream competition centers on purification, concentration efficiency, odor control, contaminant management, batch consistency, and compliance documentation; downstream demand is driven by supplement brands, infant formula companies, pharmaceutical firms, functional food manufacturers, pet nutrition brands, and CDMO customers.
Market Development Opportunities & Main Driving Factors
The core market opportunity for EPA & DHA (Omega 3) Ingredients is created by the convergence of evidence-based nutrition, sustainable sourcing, and premium dosage-form innovation. Rising consumer awareness of cardiovascular management, maternal and infant nutrition, cognitive health, eye health, and proactive wellness is shifting EPA/DHA from traditional fish oil supplementation into a high-value functional lipid platform. Algal EPA/DHA is particularly attractive because it is independent of marine fisheries and fits vegan, clean-label, sustainable sourcing, and premium infant nutrition requirements. Leading companies are also moving from conventional fish oil toward proprietary algal oils, high-concentration oils, customized formulations, and pharmaceutical-grade ingredients. With the ingredient market returning to growth in 2024, high potency, low odor, smaller serving size, traceability, and compliant labeling are becoming major levers for brand differentiation.
Market Challenges, Risks, & Restraints
The main risks lie in raw material cyclicality, price transmission, quality compliance, and the boundaries of health claims. Fish oil supply is highly exposed to Peruvian anchovy seasons, El Niño events, regional quotas, and changes in fatty acid profiles, and the supply volatility after 2023 has made inventory control, long-term procurement, and multi-source sourcing more important. Although fish oil production recovered in 2024, regional declines and pricing pressure still affect margin stability. EPA/DHA is also a nutrition ingredient with strong consumer recognition and high regulatory sensitivity, requiring strict control of contaminants, oxidation indicators, heavy metals, batch traceability, label accuracy, and health claims. For smaller players, weaker raw material bargaining power, limited concentration technology, rising certification costs, and price pressure from downstream brands will continue to compress profitability in low-end products.
Downstream Demand Trends
Downstream demand is moving from single-format fish oil softgels toward multi-scenario, precise-dosage, and better-sensory formulations. Dietary supplements remain one of the largest applications, but growth is shifting toward high-concentration EPA/DHA, smaller softgels, liquid drops, gummies, emulsions, ready-to-drink products, clinical nutrition, and pet health. Infant formula and maternal nutrition emphasize stable DHA supply and high safety standards, while the pharmaceutical segment focuses on high-purity EPA or specific EPA/DHA ratios. Future competition will no longer be determined only by oil price per kilogram; it will depend on sustainability, dosage-form compatibility, odor control, oxidative stability, regulatory documentation, and co-development capability with customers. Integrated producers with algal fermentation, fish oil concentration, pharmaceutical-grade registration, microencapsulation, and finished dosage-form capabilities are positioned to gain stronger pricing power in premium nutrition and professional health markets.
LP Information, Inc. (LPI) ' newest research report, the “EPA & DHA (Omega 3) Ingredients Industry Forecast” looks at past sales and reviews total world EPA & DHA (Omega 3) Ingredients sales in 2025, providing a comprehensive analysis by region and market sector of projected EPA & DHA (Omega 3) Ingredients sales for 2026 through 2032. With EPA & DHA (Omega 3) Ingredients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EPA & DHA (Omega 3) Ingredients industry.
This Insight Report provides a comprehensive analysis of the global EPA & DHA (Omega 3) Ingredients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EPA & DHA (Omega 3) Ingredients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EPA & DHA (Omega 3) Ingredients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EPA & DHA (Omega 3) Ingredients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EPA & DHA (Omega 3) Ingredients.
This report presents a comprehensive overview, market shares, and growth opportunities of EPA & DHA (Omega 3) Ingredients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
EPA
DHA
Segmentation by Source:
Fish Oil EPA and DHA
Algae Oil EPA and DHA
Others
Segmentation by Grade:
Food Grade
Pharma Grade
Feed Grade
Segmentation by Application:
Dietary Supplements
Fortified Food and Beverages
Infant Formula
Pharmaceuticals
Pet Food
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
dsm-firmenich
KD Pharma
Croda
BASF
Yuwang Pharma
Corbion
GC Rieber VivoMega
Pelagia (EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega (Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Roquette
Polaris
Solutex
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
ADM
Nu-Mega (Clover)
Guangdong Runke Bioengineering
Nissui
Cabio Biotech
Skuny Bioscience
Fermentalg
Renpu Pharmaceuticals
Xiamen HUISON Biotech
Xiamen Kingdomway
Algarithm
Hubei Fuxing Biological Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global EPA & DHA (Omega 3) Ingredients market?
What factors are driving EPA & DHA (Omega 3) Ingredients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EPA & DHA (Omega 3) Ingredients market opportunities vary by end market size?
How does EPA & DHA (Omega 3) Ingredients break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global EPA & DHA (Omega 3) Ingredients Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for EPA & DHA (Omega 3) Ingredients by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for EPA & DHA (Omega 3) Ingredients by Country/Region, 2021, 2025 & 2032
2.2 EPA & DHA (Omega 3) Ingredients Segment by Type
2.2.1 EPA
2.2.2 DHA
2.2.3 EPA & DHA (Omega 3) Ingredients Sales by Type
2.2.3.1 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
2.2.3.2 Global EPA & DHA (Omega 3) Ingredients Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global EPA & DHA (Omega 3) Ingredients Sale Price by Type (2021-2026)
2.3 EPA & DHA (Omega 3) Ingredients Segment by Source
2.3.1 Fish Oil EPA and DHA
2.3.2 Algae Oil EPA and DHA
2.3.3 Others
2.3.4 EPA & DHA (Omega 3) Ingredients Sales by Source
2.3.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Source (2021-2026)
2.3.4.2 Global EPA & DHA (Omega 3) Ingredients Revenue and Market Share by Source (2021-2026)
2.3.4.3 Global EPA & DHA (Omega 3) Ingredients Sale Price by Source (2021-2026)
2.4 EPA & DHA (Omega 3) Ingredients Segment by Grade
2.4.1 Food Grade
2.4.2 Pharma Grade
2.4.3 Feed Grade
2.4.4 EPA & DHA (Omega 3) Ingredients Sales by Grade
2.4.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Grade (2021-2026)
2.4.4.2 Global EPA & DHA (Omega 3) Ingredients Revenue and Market Share by Grade (2021-2026)
2.4.4.3 Global EPA & DHA (Omega 3) Ingredients Sale Price by Grade (2021-2026)
2.5 EPA & DHA (Omega 3) Ingredients Segment by Application
2.5.1 Dietary Supplements
2.5.2 Fortified Food and Beverages
2.5.3 Infant Formula
2.5.4 Pharmaceuticals
2.5.5 Pet Food
2.5.6 Others
2.5.7 EPA & DHA (Omega 3) Ingredients Sales by Application
2.5.7.1 Global EPA & DHA (Omega 3) Ingredients Sale Market Share by Application (2021-2026)
2.5.7.2 Global EPA & DHA (Omega 3) Ingredients Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global EPA & DHA (Omega 3) Ingredients Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global EPA & DHA (Omega 3) Ingredients Breakdown Data by Company
3.1.1 Global EPA & DHA (Omega 3) Ingredients Annual Sales by Company (2021-2026)
3.1.2 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Company (2021-2026)
3.2 Global EPA & DHA (Omega 3) Ingredients Annual Revenue by Company (2021-2026)
3.2.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Company (2021-2026)
3.2.2 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Company (2021-2026)
3.3 Global EPA & DHA (Omega 3) Ingredients Sale Price by Company
3.4 Key Manufacturers EPA & DHA (Omega 3) Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EPA & DHA (Omega 3) Ingredients Product Location Distribution
3.4.2 Players EPA & DHA (Omega 3) Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for EPA & DHA (Omega 3) Ingredients by Geographic Region
4.1 World Historic EPA & DHA (Omega 3) Ingredients Market Size by Geographic Region (2021-2026)
4.1.1 Global EPA & DHA (Omega 3) Ingredients Annual Sales by Geographic Region (2021-2026)
4.1.2 Global EPA & DHA (Omega 3) Ingredients Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic EPA & DHA (Omega 3) Ingredients Market Size by Country/Region (2021-2026)
4.2.1 Global EPA & DHA (Omega 3) Ingredients Annual Sales by Country/Region (2021-2026)
4.2.2 Global EPA & DHA (Omega 3) Ingredients Annual Revenue by Country/Region (2021-2026)
4.3 Americas EPA & DHA (Omega 3) Ingredients Sales Growth
4.4 APAC EPA & DHA (Omega 3) Ingredients Sales Growth
4.5 Europe EPA & DHA (Omega 3) Ingredients Sales Growth
4.6 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Growth
5 Americas
5.1 Americas EPA & DHA (Omega 3) Ingredients Sales by Country
5.1.1 Americas EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026)
5.1.2 Americas EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2026)
5.2 Americas EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026)
5.3 Americas EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EPA & DHA (Omega 3) Ingredients Sales by Region
6.1.1 APAC EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2026)
6.1.2 APAC EPA & DHA (Omega 3) Ingredients Revenue by Region (2021-2026)
6.2 APAC EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026)
6.3 APAC EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe EPA & DHA (Omega 3) Ingredients by Country
7.1.1 Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026)
7.1.2 Europe EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2026)
7.2 Europe EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026)
7.3 Europe EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa EPA & DHA (Omega 3) Ingredients by Country
8.1.1 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026)
8.1.2 Middle East & Africa EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2026)
8.2 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026)
8.3 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EPA & DHA (Omega 3) Ingredients
10.3 Manufacturing Process Analysis of EPA & DHA (Omega 3) Ingredients
10.4 Industry Chain Structure of EPA & DHA (Omega 3) Ingredients
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EPA & DHA (Omega 3) Ingredients Distributors
11.3 EPA & DHA (Omega 3) Ingredients Customer
12 World Forecast Review for EPA & DHA (Omega 3) Ingredients by Geographic Region
12.1 Global EPA & DHA (Omega 3) Ingredients Market Size Forecast by Region
12.1.1 Global EPA & DHA (Omega 3) Ingredients Forecast by Region (2027-2032)
12.1.2 Global EPA & DHA (Omega 3) Ingredients Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global EPA & DHA (Omega 3) Ingredients Forecast by Type (2027-2032)
12.7 Global EPA & DHA (Omega 3) Ingredients Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 dsm-firmenich
13.1.1 dsm-firmenich Company Information
13.1.2 dsm-firmenich EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.1.3 dsm-firmenich EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 dsm-firmenich Main Business Overview
13.1.5 dsm-firmenich Latest Developments
13.2 KD Pharma
13.2.1 KD Pharma Company Information
13.2.2 KD Pharma EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.2.3 KD Pharma EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 KD Pharma Main Business Overview
13.2.5 KD Pharma Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.3.3 Croda EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 BASF
13.4.1 BASF Company Information
13.4.2 BASF EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.4.3 BASF EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BASF Main Business Overview
13.4.5 BASF Latest Developments
13.5 Yuwang Pharma
13.5.1 Yuwang Pharma Company Information
13.5.2 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.5.3 Yuwang Pharma EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yuwang Pharma Main Business Overview
13.5.5 Yuwang Pharma Latest Developments
13.6 Corbion
13.6.1 Corbion Company Information
13.6.2 Corbion EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.6.3 Corbion EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Corbion Main Business Overview
13.6.5 Corbion Latest Developments
13.7 GC Rieber VivoMega
13.7.1 GC Rieber VivoMega Company Information
13.7.2 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.7.3 GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GC Rieber VivoMega Main Business Overview
13.7.5 GC Rieber VivoMega Latest Developments
13.8 Pelagia (EPAX)
13.8.1 Pelagia (EPAX) Company Information
13.8.2 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.8.3 Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pelagia (EPAX) Main Business Overview
13.8.5 Pelagia (EPAX) Latest Developments
13.9 Golden Omega
13.9.1 Golden Omega Company Information
13.9.2 Golden Omega EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.9.3 Golden Omega EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Golden Omega Main Business Overview
13.9.5 Golden Omega Latest Developments
13.10 TASA
13.10.1 TASA Company Information
13.10.2 TASA EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.10.3 TASA EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 TASA Main Business Overview
13.10.5 TASA Latest Developments
13.11 KinOmega Biopharm
13.11.1 KinOmega Biopharm Company Information
13.11.2 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.11.3 KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KinOmega Biopharm Main Business Overview
13.11.5 KinOmega Biopharm Latest Developments
13.12 Omega Protein
13.12.1 Omega Protein Company Information
13.12.2 Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.12.3 Omega Protein EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Omega Protein Main Business Overview
13.12.5 Omega Protein Latest Developments
13.13 Huatai Phrama
13.13.1 Huatai Phrama Company Information
13.13.2 Huatai Phrama EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.13.3 Huatai Phrama EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Huatai Phrama Main Business Overview
13.13.5 Huatai Phrama Latest Developments
13.14 AlaskOmega (Wiley Companies)
13.14.1 AlaskOmega (Wiley Companies) Company Information
13.14.2 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.14.3 AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 AlaskOmega (Wiley Companies) Main Business Overview
13.14.5 AlaskOmega (Wiley Companies) Latest Developments
13.15 Jiangsu Auqi Marine Biotechnology
13.15.1 Jiangsu Auqi Marine Biotechnology Company Information
13.15.2 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.15.3 Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Auqi Marine Biotechnology Main Business Overview
13.15.5 Jiangsu Auqi Marine Biotechnology Latest Developments
13.16 Roquette
13.16.1 Roquette Company Information
13.16.2 Roquette EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.16.3 Roquette EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Roquette Main Business Overview
13.16.5 Roquette Latest Developments
13.17 Polaris
13.17.1 Polaris Company Information
13.17.2 Polaris EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.17.3 Polaris EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Polaris Main Business Overview
13.17.5 Polaris Latest Developments
13.18 Solutex
13.18.1 Solutex Company Information
13.18.2 Solutex EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.18.3 Solutex EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Solutex Main Business Overview
13.18.5 Solutex Latest Developments
13.19 Sinomega Biotech Engineering
13.19.1 Sinomega Biotech Engineering Company Information
13.19.2 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.19.3 Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Sinomega Biotech Engineering Main Business Overview
13.19.5 Sinomega Biotech Engineering Latest Developments
13.20 Xinzhou Marine Biological Products
13.20.1 Xinzhou Marine Biological Products Company Information
13.20.2 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.20.3 Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Xinzhou Marine Biological Products Main Business Overview
13.20.5 Xinzhou Marine Biological Products Latest Developments
13.21 ADM
13.21.1 ADM Company Information
13.21.2 ADM EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.21.3 ADM EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 ADM Main Business Overview
13.21.5 ADM Latest Developments
13.22 Nu-Mega (Clover)
13.22.1 Nu-Mega (Clover) Company Information
13.22.2 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.22.3 Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Nu-Mega (Clover) Main Business Overview
13.22.5 Nu-Mega (Clover) Latest Developments
13.23 Guangdong Runke Bioengineering
13.23.1 Guangdong Runke Bioengineering Company Information
13.23.2 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.23.3 Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Guangdong Runke Bioengineering Main Business Overview
13.23.5 Guangdong Runke Bioengineering Latest Developments
13.24 Nissui
13.24.1 Nissui Company Information
13.24.2 Nissui EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.24.3 Nissui EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Nissui Main Business Overview
13.24.5 Nissui Latest Developments
13.25 Cabio Biotech
13.25.1 Cabio Biotech Company Information
13.25.2 Cabio Biotech EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.25.3 Cabio Biotech EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Cabio Biotech Main Business Overview
13.25.5 Cabio Biotech Latest Developments
13.26 Skuny Bioscience
13.26.1 Skuny Bioscience Company Information
13.26.2 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.26.3 Skuny Bioscience EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Skuny Bioscience Main Business Overview
13.26.5 Skuny Bioscience Latest Developments
13.27 Fermentalg
13.27.1 Fermentalg Company Information
13.27.2 Fermentalg EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.27.3 Fermentalg EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Fermentalg Main Business Overview
13.27.5 Fermentalg Latest Developments
13.28 Renpu Pharmaceuticals
13.28.1 Renpu Pharmaceuticals Company Information
13.28.2 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.28.3 Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Renpu Pharmaceuticals Main Business Overview
13.28.5 Renpu Pharmaceuticals Latest Developments
13.29 Xiamen HUISON Biotech
13.29.1 Xiamen HUISON Biotech Company Information
13.29.2 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.29.3 Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Xiamen HUISON Biotech Main Business Overview
13.29.5 Xiamen HUISON Biotech Latest Developments
13.30 Xiamen Kingdomway
13.30.1 Xiamen Kingdomway Company Information
13.30.2 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.30.3 Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Xiamen Kingdomway Main Business Overview
13.30.5 Xiamen Kingdomway Latest Developments
13.31 Algarithm
13.31.1 Algarithm Company Information
13.31.2 Algarithm EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.31.3 Algarithm EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Algarithm Main Business Overview
13.31.5 Algarithm Latest Developments
13.32 Hubei Fuxing Biological Technology
13.32.1 Hubei Fuxing Biological Technology Company Information
13.32.2 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
13.32.3 Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 Hubei Fuxing Biological Technology Main Business Overview
13.32.5 Hubei Fuxing Biological Technology Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. EPA & DHA (Omega 3) Ingredients Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. EPA & DHA (Omega 3) Ingredients Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of EPA
Table 4. Major Players of DHA
Table 5. Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (Tons)
Table 6. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
Table 7. Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021-2026) & ($ million)
Table 8. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2026)
Table 9. Global EPA & DHA (Omega 3) Ingredients Sale Price by Type (2021-2026) & (US$/kg)
Table 10. Major Players of Fish Oil EPA and DHA
Table 11. Major Players of Algae Oil EPA and DHA
Table 12. Major Players of Others
Table 13. Global EPA & DHA (Omega 3) Ingredients Sales by Source (2021-2026) & (Tons)
Table 14. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Source (2021-2026)
Table 15. Global EPA & DHA (Omega 3) Ingredients Revenue by Source (2021-2026) & ($ million)
Table 16. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Source (2021-2026)
Table 17. Global EPA & DHA (Omega 3) Ingredients Sale Price by Source (2021-2026) & (US$/kg)
Table 18. Major Players of Food Grade
Table 19. Major Players of Pharma Grade
Table 20. Major Players of Feed Grade
Table 21. Global EPA & DHA (Omega 3) Ingredients Sales by Grade (2021-2026) & (Tons)
Table 22. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Grade (2021-2026)
Table 23. Global EPA & DHA (Omega 3) Ingredients Revenue by Grade (2021-2026) & ($ million)
Table 24. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Grade (2021-2026)
Table 25. Global EPA & DHA (Omega 3) Ingredients Sale Price by Grade (2021-2026) & (US$/kg)
Table 26. Global EPA & DHA (Omega 3) Ingredients Sale by Application (2021-2026) & (Tons)
Table 27. Global EPA & DHA (Omega 3) Ingredients Sale Market Share by Application (2021-2026)
Table 28. Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021-2026) & ($ million)
Table 29. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2021-2026)
Table 30. Global EPA & DHA (Omega 3) Ingredients Sale Price by Application (2021-2026) & (US$/kg)
Table 31. Global EPA & DHA (Omega 3) Ingredients Sales by Company (2021-2026) & (Tons)
Table 32. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Company (2021-2026)
Table 33. Global EPA & DHA (Omega 3) Ingredients Revenue by Company (2021-2026) & ($ millions)
Table 34. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Company (2021-2026)
Table 35. Global EPA & DHA (Omega 3) Ingredients Sale Price by Company (2021-2026) & (US$/kg)
Table 36. Key Manufacturers EPA & DHA (Omega 3) Ingredients Producing Area Distribution and Sales Area
Table 37. Players EPA & DHA (Omega 3) Ingredients Products Offered
Table 38. EPA & DHA (Omega 3) Ingredients Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global EPA & DHA (Omega 3) Ingredients Sales by Geographic Region (2021-2026) & (Tons)
Table 42. Global EPA & DHA (Omega 3) Ingredients Sales Market Share Geographic Region (2021-2026)
Table 43. Global EPA & DHA (Omega 3) Ingredients Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global EPA & DHA (Omega 3) Ingredients Sales by Country/Region (2021-2026) & (Tons)
Table 46. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Country/Region (2021-2026)
Table 47. Global EPA & DHA (Omega 3) Ingredients Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (Tons)
Table 50. Americas EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2026)
Table 51. Americas EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (Tons)
Table 53. Americas EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026) & (Tons)
Table 54. APAC EPA & DHA (Omega 3) Ingredients Sales by Region (2021-2026) & (Tons)
Table 55. APAC EPA & DHA (Omega 3) Ingredients Sales Market Share by Region (2021-2026)
Table 56. APAC EPA & DHA (Omega 3) Ingredients Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (Tons)
Table 58. APAC EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026) & (Tons)
Table 59. Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (Tons)
Table 60. Europe EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (Tons)
Table 62. Europe EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026) & (Tons)
Table 63. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2026) & (Tons)
Table 64. Middle East & Africa EPA & DHA (Omega 3) Ingredients Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2026) & (Tons)
Table 66. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2026) & (Tons)
Table 67. Key Market Drivers & Growth Opportunities of EPA & DHA (Omega 3) Ingredients
Table 68. Key Market Challenges & Risks of EPA & DHA (Omega 3) Ingredients
Table 69. Key Industry Trends of EPA & DHA (Omega 3) Ingredients
Table 70. EPA & DHA (Omega 3) Ingredients Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. EPA & DHA (Omega 3) Ingredients Distributors List
Table 73. EPA & DHA (Omega 3) Ingredients Customer List
Table 74. Global EPA & DHA (Omega 3) Ingredients Sales Forecast by Region (2027-2032) & (Tons)
Table 75. Global EPA & DHA (Omega 3) Ingredients Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas EPA & DHA (Omega 3) Ingredients Sales Forecast by Country (2027-2032) & (Tons)
Table 77. Americas EPA & DHA (Omega 3) Ingredients Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC EPA & DHA (Omega 3) Ingredients Sales Forecast by Region (2027-2032) & (Tons)
Table 79. APAC EPA & DHA (Omega 3) Ingredients Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe EPA & DHA (Omega 3) Ingredients Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Europe EPA & DHA (Omega 3) Ingredients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Forecast by Country (2027-2032) & (Tons)
Table 83. Middle East & Africa EPA & DHA (Omega 3) Ingredients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global EPA & DHA (Omega 3) Ingredients Sales Forecast by Type (2027-2032) & (Tons)
Table 85. Global EPA & DHA (Omega 3) Ingredients Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global EPA & DHA (Omega 3) Ingredients Sales Forecast by Application (2027-2032) & (Tons)
Table 87. Global EPA & DHA (Omega 3) Ingredients Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. dsm-firmenich Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 89. dsm-firmenich EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 90. dsm-firmenich EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. dsm-firmenich Main Business
Table 92. dsm-firmenich Latest Developments
Table 93. KD Pharma Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 94. KD Pharma EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 95. KD Pharma EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. KD Pharma Main Business
Table 97. KD Pharma Latest Developments
Table 98. Croda Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 99. Croda EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 100. Croda EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Croda Main Business
Table 102. Croda Latest Developments
Table 103. BASF Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 104. BASF EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 105. BASF EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. BASF Main Business
Table 107. BASF Latest Developments
Table 108. Yuwang Pharma Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 109. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 110. Yuwang Pharma EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Yuwang Pharma Main Business
Table 112. Yuwang Pharma Latest Developments
Table 113. Corbion Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 114. Corbion EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 115. Corbion EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Corbion Main Business
Table 117. Corbion Latest Developments
Table 118. GC Rieber VivoMega Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 119. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 120. GC Rieber VivoMega EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. GC Rieber VivoMega Main Business
Table 122. GC Rieber VivoMega Latest Developments
Table 123. Pelagia (EPAX) Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 124. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 125. Pelagia (EPAX) EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. Pelagia (EPAX) Main Business
Table 127. Pelagia (EPAX) Latest Developments
Table 128. Golden Omega Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 129. Golden Omega EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 130. Golden Omega EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. Golden Omega Main Business
Table 132. Golden Omega Latest Developments
Table 133. TASA Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 134. TASA EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 135. TASA EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. TASA Main Business
Table 137. TASA Latest Developments
Table 138. KinOmega Biopharm Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 139. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 140. KinOmega Biopharm EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. KinOmega Biopharm Main Business
Table 142. KinOmega Biopharm Latest Developments
Table 143. Omega Protein Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 144. Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 145. Omega Protein EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 146. Omega Protein Main Business
Table 147. Omega Protein Latest Developments
Table 148. Huatai Phrama Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 149. Huatai Phrama EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 150. Huatai Phrama EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 151. Huatai Phrama Main Business
Table 152. Huatai Phrama Latest Developments
Table 153. AlaskOmega (Wiley Companies) Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 154. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 155. AlaskOmega (Wiley Companies) EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 156. AlaskOmega (Wiley Companies) Main Business
Table 157. AlaskOmega (Wiley Companies) Latest Developments
Table 158. Jiangsu Auqi Marine Biotechnology Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 160. Jiangsu Auqi Marine Biotechnology EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 161. Jiangsu Auqi Marine Biotechnology Main Business
Table 162. Jiangsu Auqi Marine Biotechnology Latest Developments
Table 163. Roquette Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 164. Roquette EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 165. Roquette EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 166. Roquette Main Business
Table 167. Roquette Latest Developments
Table 168. Polaris Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 169. Polaris EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 170. Polaris EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 171. Polaris Main Business
Table 172. Polaris Latest Developments
Table 173. Solutex Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 174. Solutex EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 175. Solutex EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 176. Solutex Main Business
Table 177. Solutex Latest Developments
Table 178. Sinomega Biotech Engineering Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 179. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 180. Sinomega Biotech Engineering EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 181. Sinomega Biotech Engineering Main Business
Table 182. Sinomega Biotech Engineering Latest Developments
Table 183. Xinzhou Marine Biological Products Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 184. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 185. Xinzhou Marine Biological Products EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 186. Xinzhou Marine Biological Products Main Business
Table 187. Xinzhou Marine Biological Products Latest Developments
Table 188. ADM Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 189. ADM EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 190. ADM EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 191. ADM Main Business
Table 192. ADM Latest Developments
Table 193. Nu-Mega (Clover) Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 194. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 195. Nu-Mega (Clover) EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 196. Nu-Mega (Clover) Main Business
Table 197. Nu-Mega (Clover) Latest Developments
Table 198. Guangdong Runke Bioengineering Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 199. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 200. Guangdong Runke Bioengineering EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 201. Guangdong Runke Bioengineering Main Business
Table 202. Guangdong Runke Bioengineering Latest Developments
Table 203. Nissui Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 204. Nissui EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 205. Nissui EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 206. Nissui Main Business
Table 207. Nissui Latest Developments
Table 208. Cabio Biotech Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 209. Cabio Biotech EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 210. Cabio Biotech EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 211. Cabio Biotech Main Business
Table 212. Cabio Biotech Latest Developments
Table 213. Skuny Bioscience Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 214. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 215. Skuny Bioscience EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 216. Skuny Bioscience Main Business
Table 217. Skuny Bioscience Latest Developments
Table 218. Fermentalg Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 219. Fermentalg EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 220. Fermentalg EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 221. Fermentalg Main Business
Table 222. Fermentalg Latest Developments
Table 223. Renpu Pharmaceuticals Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 224. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 225. Renpu Pharmaceuticals EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 226. Renpu Pharmaceuticals Main Business
Table 227. Renpu Pharmaceuticals Latest Developments
Table 228. Xiamen HUISON Biotech Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 229. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 230. Xiamen HUISON Biotech EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 231. Xiamen HUISON Biotech Main Business
Table 232. Xiamen HUISON Biotech Latest Developments
Table 233. Xiamen Kingdomway Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 234. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 235. Xiamen Kingdomway EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 236. Xiamen Kingdomway Main Business
Table 237. Xiamen Kingdomway Latest Developments
Table 238. Algarithm Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 239. Algarithm EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 240. Algarithm EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 241. Algarithm Main Business
Table 242. Algarithm Latest Developments
Table 243. Hubei Fuxing Biological Technology Basic Information, EPA & DHA (Omega 3) Ingredients Manufacturing Base, Sales Area and Its Competitors
Table 244. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Product Portfolios and Specifications
Table 245. Hubei Fuxing Biological Technology EPA & DHA (Omega 3) Ingredients Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 246. Hubei Fuxing Biological Technology Main Business
Table 247. Hubei Fuxing Biological Technology Latest Developments


List of Figures
Figure 1. Picture of EPA & DHA (Omega 3) Ingredients
Figure 2. EPA & DHA (Omega 3) Ingredients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EPA & DHA (Omega 3) Ingredients Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global EPA & DHA (Omega 3) Ingredients Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. EPA & DHA (Omega 3) Ingredients Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. EPA & DHA (Omega 3) Ingredients Sales Market Share by Country/Region (2025)
Figure 10. EPA & DHA (Omega 3) Ingredients Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of EPA
Figure 12. Product Picture of DHA
Figure 13. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type in 2026
Figure 14. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Fish Oil EPA and DHA
Figure 16. Product Picture of Algae Oil EPA and DHA
Figure 17. Product Picture of Others
Figure 18. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Source in 2026
Figure 19. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Source (2021-2026)
Figure 20. Product Picture of Food Grade
Figure 21. Product Picture of Pharma Grade
Figure 22. Product Picture of Feed Grade
Figure 23. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Grade in 2026
Figure 24. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Grade (2021-2026)
Figure 25. EPA & DHA (Omega 3) Ingredients Consumed in Dietary Supplements
Figure 26. Global EPA & DHA (Omega 3) Ingredients Market: Dietary Supplements (2021-2026) & (Tons)
Figure 27. EPA & DHA (Omega 3) Ingredients Consumed in Fortified Food and Beverages
Figure 28. Global EPA & DHA (Omega 3) Ingredients Market: Fortified Food and Beverages (2021-2026) & (Tons)
Figure 29. EPA & DHA (Omega 3) Ingredients Consumed in Infant Formula
Figure 30. Global EPA & DHA (Omega 3) Ingredients Market: Infant Formula (2021-2026) & (Tons)
Figure 31. EPA & DHA (Omega 3) Ingredients Consumed in Pharmaceuticals
Figure 32. Global EPA & DHA (Omega 3) Ingredients Market: Pharmaceuticals (2021-2026) & (Tons)
Figure 33. EPA & DHA (Omega 3) Ingredients Consumed in Pet Food
Figure 34. Global EPA & DHA (Omega 3) Ingredients Market: Pet Food (2021-2026) & (Tons)
Figure 35. EPA & DHA (Omega 3) Ingredients Consumed in Others
Figure 36. Global EPA & DHA (Omega 3) Ingredients Market: Others (2021-2026) & (Tons)
Figure 37. Global EPA & DHA (Omega 3) Ingredients Sale Market Share by Application (2025)
Figure 38. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application in 2025
Figure 39. EPA & DHA (Omega 3) Ingredients Sales by Company in 2025 (Tons)
Figure 40. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Company in 2025
Figure 41. EPA & DHA (Omega 3) Ingredients Revenue by Company in 2025 ($ millions)
Figure 42. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Company in 2025
Figure 43. Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Geographic Region in 2025
Figure 45. Americas EPA & DHA (Omega 3) Ingredients Sales 2021-2026 (Tons)
Figure 46. Americas EPA & DHA (Omega 3) Ingredients Revenue 2021-2026 ($ millions)
Figure 47. APAC EPA & DHA (Omega 3) Ingredients Sales 2021-2026 (Tons)
Figure 48. APAC EPA & DHA (Omega 3) Ingredients Revenue 2021-2026 ($ millions)
Figure 49. Europe EPA & DHA (Omega 3) Ingredients Sales 2021-2026 (Tons)
Figure 50. Europe EPA & DHA (Omega 3) Ingredients Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales 2021-2026 (Tons)
Figure 52. Middle East & Africa EPA & DHA (Omega 3) Ingredients Revenue 2021-2026 ($ millions)
Figure 53. Americas EPA & DHA (Omega 3) Ingredients Sales Market Share by Country in 2025
Figure 54. Americas EPA & DHA (Omega 3) Ingredients Revenue Market Share by Country (2021-2026)
Figure 55. Americas EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
Figure 56. Americas EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2026)
Figure 57. United States EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC EPA & DHA (Omega 3) Ingredients Sales Market Share by Region in 2025
Figure 62. APAC EPA & DHA (Omega 3) Ingredients Revenue Market Share by Region (2021-2026)
Figure 63. APAC EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
Figure 64. APAC EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2026)
Figure 65. China EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 69. India EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe EPA & DHA (Omega 3) Ingredients Sales Market Share by Country in 2025
Figure 73. Europe EPA & DHA (Omega 3) Ingredients Revenue Market Share by Country (2021-2026)
Figure 74. Europe EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
Figure 75. Europe EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2026)
Figure 76. Germany EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 77. France EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 78. UK EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2026)
Figure 84. Egypt EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries EPA & DHA (Omega 3) Ingredients Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of EPA & DHA (Omega 3) Ingredients in 2026
Figure 90. Manufacturing Process Analysis of EPA & DHA (Omega 3) Ingredients
Figure 91. Industry Chain Structure of EPA & DHA (Omega 3) Ingredients
Figure 92. Channels of Distribution
Figure 93. Global EPA & DHA (Omega 3) Ingredients Sales Market Forecast by Region (2027-2032)
Figure 94. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global EPA & DHA (Omega 3) Ingredients Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global EPA & DHA (Omega 3) Ingredients Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global EPA & DHA (Omega 3) Ingredients Revenue Market Share Forecast by Application (2027-2032)